Cure My Disease

Don't miss your cure!

 Log in / Sign up

Digital watchdogs: can apps catch post-surgery prostate problems early?

NCT ID NCT05644821

Symptom relief Sponsor: Heinrich-Heine University, Duesseldorf Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 27, 2026 · Last updated Aug 28, 2026 · Updated 1 time

Summary

This trial tests whether regular electronic questionnaires after prostate cancer surgery can improve recovery. Men who have their prostate removed will report symptoms like incontinence and mood through an app or computer. If scores hit certain levels, a nurse calls to offer a urology consultation. The study compares this active monitoring to usual care to see if it leads to better continence, fewer symptoms, and higher quality of life in the first year after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Electronic patient-reported outcome monitoring (ePROMs) with alerts and nurse-led follow-up
What this could lead to
If it works, this approach could help men recover better after prostate cancer surgery by catching problems like incontinence early and improving quality of life.
What could go wrong
The trial is relatively small and the benefit may be modest. Extra monitoring could also increase anxiety or lead to unnecessary consultations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

260 people

The number who actually took part.

Started

Aug 2023

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * age ≥ 18 y * legal capacity * sufficient knowledge of the German language * prostate carcinoma, TNM T1-4 NX N0-1 M0-1c * primary radical prostatectomy planned * mobile input device or PC available * ability to either receive emails or install a special app on cell phone and receive push messages, with guidance or assistance if necessary * ability to complete electronic questionnaires, with guidance or assistance if necessary Exclusion Criteria: * palliative treatment situation (life expectancy \< 1 year) * preoperative urinary incontinence (at least one pad per 24 hours)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Prostate cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Prostate cancer

Contacts and locations

Locations

  • Klinikum Dortmund gGmbH, Urology

    Dortmund, North Rhine-Westphalia, 44145, Germany

  • University Clinic Bonn, Urology

    Bonn, North Rhine Westpahlia, 53127, Germany

  • University Clinic Düsseldorf, Urology

    Düsseldorf, North Rhine-Westphalia, 40223, Germany

  • University Clinic Münster, Urology

    Münster, North Rhine-Westphalia, 48149, Germany

  • University Clinik Bochum, Marienhospital Herne, Urology

    Herne, North Rhine-Westphalia, 44625, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.